Communiqués

08/10/21 Taiwan Liposome : Filings with the Taipei Exchange’s Market Observation Post System, dated October 8, 2021 - Form 6-K PU
09/09/21 Taiwan Liposome : TLC to Present at Upcoming Virtual Investor Conferences PU
08/09/21 Taiwan Liposome : TLC Announces Voluntary Delisting and Deregistration of American Depositary Shares (Form 6-K) PU
27/08/21 Taiwan Liposome : ANNUAL GENERAL MEETING MINUTES (Form 6-K) PU
26/08/21 Taiwan Liposome : 2021 First EGM Minutes PU
26/08/21 Taiwan Liposome : 2021 AGM Minutes PU
16/08/21 Taiwan Liposome : 2021 Q2 Consolidated Financial Statements PU
12/08/21 Taiwan Liposome : TLC Reports Second Quarter 2021 Financial Results and Provides Business Update (Form 6-K) PU
12/08/21 Taiwan Liposome : TLC Reports Second Quarter 2021 Financial Results and Provides Business Update PU
04/08/21 Taiwan Liposome : In case of any discrepancy between the English and the Chinese version, the Chinese version shall prevail (Form 6-K) PU
04/08/21 Taiwan Liposome : 1st Amendment to the Share Swap Agreement PU
04/08/21 Taiwan Liposome : Handbook for First Extraordinary General Meeting of 2021 (international shareholder other than ADS holders) PU
04/08/21 Taiwan Liposome : 2021 EGM Notice PU
23/07/21 Taiwan Liposome : 2021 EGM Agenda PU
22/07/21 Type of merger and acquisition (e.g. merger, spin-off, acquisition, or share transfer): Share Swap (Form 6-K) PU
06/07/21 Taiwan Liposome : TLC Announces Details of Stock Swap Transactions (Form 6-K) PU
30/06/21 Taiwan Liposome : TLC and Endo Enter Commercialization Agreement PU
30/05/21 Taiwan Liposome : AmphoTLC™ Lifts Off for Delivery to India PU
28/05/21 Taiwan Liposome : Notice of 2021 Annual General Meeting (Summary translation, for reference only) (Form 6-K) PU
27/05/21 Taiwan Liposome : TLC and Strides Enter Agreement for AmphoTLC™ in India PU
26/05/21 Taiwan Liposome : TLC and Zydus Enter Agreement to Launch AmphoTLC™ in India PU
25/05/21 Taiwan Liposome : TLC Announces Approval of New Drug Application of Liposomal Amphotericin B in India PU
23/05/21 Taiwan Liposome : InspirMed Highlights Encouraging Data on ISPM21 and ISPM19 – Inhalable Liposome Formulations of Antiviral Drugs for COVID-19 PU
18/05/21 Taiwan Liposome : 2021 Q1 Consolidated Financial Statements PU
11/05/21 Taiwan Liposome : 2021 AGM Agenda PU
Aucun résultat pour cette recherche